The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and ...
Ace Therapeutics announced custom animal models of hypertension, designed to help understand hypertension pathogenesis ...
Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule BLX-7006 reduced the weight of obese mice by 15% over a 28-day span. "We ...
LANSING, Mich. (WLNS) — Researchers at Michigan State University have successfully performed CRISPR-based genome editing in Nile grass rats, the first ever successful genome editing in the species.
SAN FRANCISCO and SUZHOU, China, April 27, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Cadena Research empowers radiopharmaceutical innovators by delivering tailored solutions that accelerate the path to clinical translation. HAMILTON, ON, Sept. 29, 2025 /PRNewswire/ - CPDC, a global ...
Charles River Laboratories and Sanofi are working on a new project in which virtual control animals will take the place of live ones in preclinical research, the companies announced June 5. No terms ...
Neurodegenerative diseases, such as Alzheimer's Disease (AD) and Parkinson's Disease (PD), are a growing societal burden as the aging population increases. Several neuropathological processes, such as ...
The oral presentation discussed GPX-002, the diabetes gene therapy, which uses infusion of recombinant adeno-associated virus (rAAV) retrograde into the pancreatic duct to deliver the Pdx1 and MafA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results